LiPlasome Pharma AS
Executive Summary
LiPlasome Pharma AS was established in January 2001 to commercialize its novel lipid-based drug delivery platform based on engineered liposomes dubbed liplasomes. LiPlasome is applying its technology to the oncology arena, to both improve upon existing drugs' safety and efficacy and to develop novel lipid-based compounds.